Apollo Hospitals Share Price Climbs to Intraday Peak with 5.68% Gain

Apollo Hospitals Enterprise Ltd. grabbed market attention on 11 February 2026 when its share price climbed sharply, hitting an intraday peak with a 5.68% gain amid active trading interest and strong earnings news. This move stood out on a day when broader indices like the Sensex and Nifty showed only modest movement, underscoring renewed investor confidence in the healthcare giant. 

The surge was fueled in part by a robust quarterly performance, including a 35% year‑on‑year jump in consolidated net profit, which has analysts and traders talking. But what exactly is driving the buying pressure, and can this momentum last?

Let’s unpack the factors behind Apollo’s recent rally and what it could mean for investors going forward.

Apollo Hospitals Share Price Surge and What It Means for Investors

Intraday Momentum: Share Gains 5.68% on February 11, 2026

Apollo Hospitals Enterprise Ltd. delivered a strong performance on 11 February 2026, with its share price climbing to an intraday high of ₹7,570, marking a 5.68% gain amid active trading and clear buying pressure. This move stood out as broader market indices like the Sensex showed more muted trends that day, highlighting investors’ renewed interest in the healthcare giant.

Trading strength was backed by a gap‑up opening of about 2.49% and the stock staying above key moving averages, a technical signal often watched by traders as a sign of sustained momentum.

Latest Financial Performance: Solid Growth Across Segments

Q3 FY26 Profit and Revenue Trends

In its third quarter of fiscal 2025-26 (Q3 FY26) results, Apollo Hospitals reported robust growth:

• Net profit jumped 35% YoY to ₹502 crore, up from ₹372 crore in the same period last year.
• Revenue rose 17% year‑on‑year to ₹6,477 crore.
• EBITDA expanded 27% to ₹965 crore, indicating improved operational efficiency.

#Q3WithETNOW | Apollo Hospitals Q3: Profit up 34.9% YoY and revenue rises 17.2%#StockMarket #EarningsWithETNOW pic.twitter.com/zausFSx4hG

— ET NOW (@ETNOWlive) February 10, 2026

The board also declared an interim dividend of ₹10 per share, signalling confidence in the company’s earnings trajectory.

Healthcare services saw revenue growth and stable margins, while HealthCo (digital health and omni‑channel pharmacy) delivered strong segmental expansion with new store additions and rising online transactions.

These results underscore consistent demand for private healthcare services and diversified revenue streams across Apollo’s ecosystem.

What Drives Investor Confidence?

Strong Operational Metrics

Apollo’s core hospital business reported:

• Rising inpatient volume and case mix improvements.
• Occupancy levels are around the mid‑ to high‑60% range, supporting steady revenue growth.
• An increase in average revenue per inpatient, highlighting value delivery.

These data points suggest underlying fundamentals are strengthening, which supports equity valuation and investor interest.

Apollo Hospitals: Stock Details & Forecast from Meyka

What Meyka Says About Apollo Hospitals Stock?

According to Meyka’s latest stock overview, Apollo Hospitals Enterprise Ltd (NSE: APOLLOHOSP.NS) trades around current levels near ₹7,000+, with a market cap of around ₹1 trillion. Fundamental metrics show a P/E ratio above 60 and moderate ROE, indicating premium valuation levels relative to earnings.

Meyka’s technical snapshot suggests a bearish short‑term sentiment on current price action, weighed by selling and weak momentum signals.

However, forecast models on the same platform point to a potential upside over the next 12 months, with a target price above recent levels, suggesting investors may see incremental gains if fundamentals hold.

This mix of short‑term caution and longer‑term forecast highlights why many traders complement fundamental news with AI‑enhanced tools and technical overlays before making decisions.

How Do Analysts View the Stock?

Broader Market and Broker Insights

Beyond Meyka’s outlook, several brokerages continue to maintain positive long‑term views on 

Apollo Hospitals stock:

• Some investment banks have maintained buy recommendations and raised price targets based on growth prospects, strong earnings delivery, and expansion plans.

These analysts’ views reinforce the narrative that Apollo’s expanding footprint and diversified services could support future growth, though valuations remain stretched compared with historic averages.

What Investors Should Watch Next for Apollo Stock?

Key Catalysts and Risks

Positive Drivers:

• Expansion of hospital capacity and new facilities across major cities.
• Continued growth in the pharmacy and digital healthcare segments.
• Improving margins and dividend payouts.

Strong quarter for #ApolloHospitals.

Growth across hospitals, diagnostics, and the pharmacy network.

MD Suneeta Reddy outlines what’s driving momentum and what comes next.@HospitalsApollo @SuneetaReddy4 @_nirajshah
Watch Live: https://t.co/AQ0AvKG6MQ pic.twitter.com/4fiZfzRF8Z

— NDTV Profit (@NDTVProfitIndia) February 11, 2026

Potential Challenges:

• High P/E and premium valuation.
• Market volatility and macroeconomic headwinds are affecting sentiment.
• Short‑term technical sell pressure as flagged by tools like Meyka.

Monitoring upcoming quarterly earnings, occupancy trends, and segmental performance will be crucial for anticipating future price movement.

Final Thought

Apollo Hospitals’ intraday surge to 5.68% on 11 February 2026 reflects both strong results and investor confidence in the broader healthcare recovery story in India. While short‑term technical indicators show caution, consistent earnings growth and strategic expansion plans position the stock as one to watch over the long term, especially for investors focused on healthcare sector fundamentals and earnings momentum. 

Frequently Asked Questions (FAQs)

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.